Principal Financial Group Inc Pmv Pharmaceuticals, Inc. Transaction History

Principal Financial Group Inc

$172 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$1.51 - $3.12 $2,168 - $4,480	-1,436 Reduced 9.2%	14,180 $24,000
Q4 2023 Feb 07, 2024	SELL	$1.23 - $6.6 $1.11 Million - $5.96 Million	-903,526 Reduced 98.3%	15,616 $48,000
Q3 2023 Nov 02, 2023	SELL	$6.01 - $8.93 $45,633 - $67,805	-7,593 Reduced 0.82%	919,142 $5.64 Million
Q2 2023 Aug 07, 2023	BUY	$3.94 - $6.27 $34,869 - $55,489	8,850 Added 0.96%	926,735 $5.8 Million
Q1 2023 May 09, 2023	BUY	$4.77 - $9.16 $105,030 - $201,694	22,019 Added 2.46%	917,885 $4.38 Million
Q4 2022 Feb 09, 2023	SELL	$8.17 - $12.95 $424,921 - $673,529	-52,010 Reduced 5.49%	895,866 $7.79 Million
Q3 2022 Nov 09, 2022	BUY	$11.4 - $17.18 $1.44 Million - $2.18 Million	126,644 Added 15.42%	947,876 $11.3 Million
Q2 2022 Aug 10, 2022	BUY	$9.23 - $22.43 $1.87 Million - $4.54 Million	202,306 Added 32.69%	821,232 $11.7 Million
Q1 2022 May 09, 2022	BUY	$14.86 - $23.55 $326,385 - $517,252	21,964 Added 3.68%	618,926 $12.9 Million
Q4 2021 Feb 09, 2022	BUY	$19.99 - $30.24 $2.14 Million - $3.24 Million	107,027 Added 21.85%	596,962 $13.8 Million
Q3 2021 Nov 09, 2021	BUY	$26.84 - $36.58 $752,110 - $1.03 Million	28,022 Added 6.07%	489,935 $14.6 Million
Q2 2021 Aug 10, 2021	BUY	$28.01 - $36.01 $7.38 Million - $9.49 Million	263,491 Added 132.79%	461,913 $15.8 Million
Q1 2021 May 10, 2021	BUY	$30.66 - $49.5 $60,308 - $97,366	1,967 Added 1.0%	198,422 $6.53 Million
Q4 2020 Feb 08, 2021	SELL	$31.86 - $61.51 $138,431 - $267,260	-4,345 Reduced 2.16%	196,455 $12.1 Million
Q3 2020 Nov 06, 2020	BUY	$35.5 - $38.0 $7.13 Million - $7.63 Million	200,800 New	200,800 $7.13 Million

Others Institutions Holding PMVP

# of Institutions

Shares Held

41.9M

Call Options Held

3.1K

Put Options Held

1.7K

Orbimed Advisors LLC San Diego, CA

6.48M
Shares

$10.4 Million
0.23% of portfolio
Arrow Mark Colorado Holdings LLC Denver, CO

3.65M
Shares

$5.87 Million
0.08% of portfolio
Sio Capital Management, LLC New York, NY

3.21M
Shares

$5.17 Million
2.53% of portfolio
Euclidean Capital LLC New York, NY

2.63M
Shares

$4.23 Million
0.43% of portfolio
Alkeon Capital Management LLC New York, NY

2.34M
Shares

$3.77 Million
0.01% of portfolio

View Full List

About PMV Pharmaceuticals, Inc.

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

More about PMVP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account